Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $1.66 billion. The enterprise value is $1.18 billion.
Important Dates
The last earnings date was Wednesday, April 8, 2026, before market open.
| Earnings Date | Apr 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NRIX has 103.41 million shares outstanding. The number of shares has increased by 25.59% in one year.
| Current Share Class | 103.41M |
| Shares Outstanding | 103.41M |
| Shares Change (YoY) | +25.59% |
| Shares Change (QoQ) | +15.76% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 94.23% |
| Float | 87.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.09 |
| Forward PS | 24.07 |
| PB Ratio | 3.45 |
| P/TBV Ratio | 3.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.01 |
| Quick Ratio | 5.89 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.40% and return on invested capital (ROIC) is -37.64%.
| Return on Equity (ROE) | -61.40% |
| Return on Assets (ROA) | -31.50% |
| Return on Invested Capital (ROIC) | -37.64% |
| Return on Capital Employed (ROCE) | -57.97% |
| Weighted Average Cost of Capital (WACC) | 14.61% |
| Revenue Per Employee | $226,432 |
| Profits Per Employee | -$931,483 |
| Employee Count | 317 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $760,000 in taxes.
| Income Tax | 760,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.98% in the last 52 weeks. The beta is 1.98, so NRIX's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | +66.98% |
| 50-Day Moving Average | 15.75 |
| 200-Day Moving Average | 13.77 |
| Relative Strength Index (RSI) | 54.00 |
| Average Volume (20 Days) | 1,483,655 |
Short Selling Information
The latest short interest is 16.18 million, so 15.65% of the outstanding shares have been sold short.
| Short Interest | 16.18M |
| Short Previous Month | 15.97M |
| Short % of Shares Out | 15.65% |
| Short % of Float | 18.57% |
| Short Ratio (days to cover) | 19.28 |
Income Statement
In the last 12 months, NRIX had revenue of $71.78 million and -$295.28 million in losses. Loss per share was -$3.17.
| Revenue | 71.78M |
| Gross Profit | -259.60M |
| Operating Income | -315.30M |
| Pretax Income | -294.52M |
| Net Income | -295.28M |
| EBITDA | -307.31M |
| EBIT | -315.30M |
| Loss Per Share | -$3.17 |
Full Income StatementBalance Sheet
The company has $540.73 million in cash and $58.66 million in debt, with a net cash position of $482.08 million or $4.66 per share.
| Cash & Cash Equivalents | 540.73M |
| Total Debt | 58.66M |
| Net Cash | 482.08M |
| Net Cash Per Share | $4.66 |
| Equity (Book Value) | 480.89M |
| Book Value Per Share | 4.65 |
| Working Capital | 462.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$260.29 million and capital expenditures -$11.56 million, giving a free cash flow of -$271.85 million.
| Operating Cash Flow | -260.29M |
| Capital Expenditures | -11.56M |
| Depreciation & Amortization | 7.99M |
| Net Borrowing | n/a |
| Free Cash Flow | -271.85M |
| FCF Per Share | -$2.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -439.26% |
| Pretax Margin | -410.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.59% |
| Shareholder Yield | -25.59% |
| Earnings Yield | -17.81% |
| FCF Yield | -16.40% |
Analyst Forecast
The average price target for NRIX is $30.50, which is 90.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.50 |
| Price Target Difference | 90.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 43.02% |
| EPS Growth Forecast (5Y) | -62.67% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 1.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.31 |
| Piotroski F-Score | 1 |
